{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:37:03Z","timestamp":1793371023457,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jaad.2026.09.059","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:19:44Z","timestamp":1790003984000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world systemic treatment outcomes for moderate-to-severe atopic dermatitis in children by skin color: 4-year results from the observational, international, real-world PEDISTAD registry"],"prefix":"10.1016","author":[{"given":"Amy S.","family":"Paller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Wine Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Ramien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri Igor","family":"L\u00f3pez Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel C.","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes E.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korey","family":"Capozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ardeleanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jaad.2026.09.059_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.4081\/dr.2012.e1","article-title":"Atopic dermatitis in adolescence","volume":"4","author":"Ricci","year":"2012","journal-title":"Dermatol Reports"},{"issue":"4","key":"10.1016\/j.jaad.2026.09.059_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.anai.2020.12.020","article-title":"Atopic dermatitis in the pediatric population: a cross-sectional, international epidemiologic study","volume":"126","author":"Silverberg","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2026.09.059_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.aller.2012.03.001","article-title":"The International Study of Asthma and Allergies in Childhood (ISAAC) phase three: a global synthesis","volume":"41","author":"Mallol","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.jaad.2026.09.059_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2147\/DDDT.S426947","article-title":"Dupilumab treatment in pediatric patients aged 6-11 years with severe atopic dermatitis whose disease is not adequately controlled: a review","volume":"18","author":"Cork","year":"2024","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"10.1016\/j.jaad.2026.09.059_bib5","doi-asserted-by":"crossref","first-page":"AB31","DOI":"10.1016\/j.jaci.2020.12.149","article-title":"Children with Atopic Dermatitis (AD) have a high burden of atopic comorbidities: results from a Large Worldwide Survey","volume":"147","author":"Silverberg","year":"2021","journal-title":"J Allergy Clin Immun"},{"issue":"3","key":"10.1016\/j.jaad.2026.09.059_bib6","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.anai.2018.07.006","article-title":"Patient burden and quality of life in atopic dermatitis in US adults: a population-based cross-sectional study","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2026.09.059_bib7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/jdv.19500","article-title":"Real-world clinical, psychosocial and economic burden of atopic dermatitis: results from a multicountry study","volume":"38","author":"Eyerich","year":"2024","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2026.09.059_bib8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jaad.2022.01.018","article-title":"Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: interim results from the PEDISTAD Real-World Registry","volume":"87","author":"Paller","year":"2022","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.09.059_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.anai.2024.09.022","article-title":"The paradigm shift in drug development for atopic dermatitis: addressing the variables of the equation leading to disease modification","volume":"134","author":"Bieber","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.jaad.2026.09.059_bib10","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/exd.13514","article-title":"Atopic dermatitis in diverse racial and ethnic groups-variations in epidemiology, genetics, clinical presentation and treatment","volume":"27","author":"Kaufman","year":"2018","journal-title":"Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.09.059_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/ijd.15805","article-title":"Association between atopic dermatitis and race from infancy to early childhood: a retrospective cohort study","volume":"61","author":"Monir","year":"2022","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.09.059_bib12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jid.2018.10.029","article-title":"Racial\/ethnic differences in incidence and persistence of childhood atopic dermatitis","volume":"139","author":"Kim","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.09.059_bib13","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.anai.2020.01.001","article-title":"Racial disparities in allergic outcomes persist to age 10 years in black and white children","volume":"124","author":"Sitarik","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.jaad.2026.09.059_bib14","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.anai.2018.11.015","article-title":"Racial differences in atopic dermatitis","volume":"122","author":"Brunner","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2026.09.059_bib15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jdin.2022.09.006","article-title":"Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types","volume":"10","author":"Bosma","year":"2023","journal-title":"JAAD Int"},{"issue":"10","key":"10.1016\/j.jaad.2026.09.059_bib16","doi-asserted-by":"crossref","first-page":"673","DOI":"10.31128\/AJGP-01-23-6684","article-title":"Diagnosis, assessment and management of atopic dermatitis in children with skin of colour","volume":"52","author":"Gan","year":"2023","journal-title":"Aust J Gen Pract"},{"key":"10.1016\/j.jaad.2026.09.059_bib17","article-title":"Managing childhood and adolescent atopic dermatitis in primary care: a US expert group consensus","volume":"14","author":"Boguniewicz","year":"2024","journal-title":"J Pediatr Clin Pract"},{"issue":"10356","key":"10.1016\/j.jaad.2026.09.059_bib18","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0140-6736(22)01539-2","article-title":"Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"400","author":"Paller","year":"2022","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.jaad.2026.09.059_bib19","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.jaad.2020.06.054","article-title":"Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double-blinded, placebo-controlled phase 3 trial","volume":"83","author":"Paller","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.09.059_bib20","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.anai.2022.12.017","article-title":"Proposed solutions by the American College of Allergy, Asthma, and Immunology and advocacy experts to address racial disparities in atopic dermatitis and food allergy","volume":"130","author":"Corbett","year":"2023","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2026.09.059_bib21","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/bjd\/ljae322","article-title":"Examining racial and ethnic disparities in diagnosis and access to care in infantile atopic dermatitis in the USA: a retrospective cohort study","volume":"192","author":"Servattalab","year":"2024","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2026.09.059_bib22","article-title":"Racial and ethnic disparities in dupilumab for pediatric atopic dermatitis in Florida","volume":"3","author":"Jonsdottir","year":"2024","journal-title":"J Allergy Clin Immunol Glob"},{"issue":"6","key":"10.1016\/j.jaad.2026.09.059_bib23","first-page":"650","article-title":"Racial and ethnic disparities in access to emerging and frontline therapies in common dermatological conditions: a cross-sectional study","volume":"112","author":"Bell","year":"2020","journal-title":"J Natl Med Assoc"},{"issue":"9","key":"10.1016\/j.jaad.2026.09.059_bib24","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1016\/j.jaip.2022.06.014","article-title":"Dupilumab improves clinical scores in children and adolescents with moderate to severe atopic dermatitis: a real-world, single-center study","volume":"10","author":"Pagan","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.jaad.2026.09.059_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.36849\/JDD.85852","article-title":"Dupilumab treatment improves lichenification in atopic dermatitis in different age and racial groups","volume":"24","author":"Guttman-Yassky","year":"2025","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.09.059_bib26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40257-025-00962-8","article-title":"Systemic treatments in moderate-to-severe atopic dermatitis in pediatric patients up to 12 years of age: real-world treatment outcomes from the PEDISTAD registry","volume":"26","author":"Paller","year":"2025","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.09.059_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033507","article-title":"Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology","volume":"10","author":"Paller","year":"2020","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jaad.2026.09.059_bib28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/bjd.13662","article-title":"What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study","volume":"172","author":"Leshem","year":"2015","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2026.09.059_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaad.2023.08.104","article-title":"Development and validation of a caregiver-reported Numeric Rating Scale for measuring worst scratch\/itch in patients aged 6 months to younger than 6 years with atopic dermatitis","volume":"90","author":"Paller","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.09.059_bib30","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2133.2001.03960.x","article-title":"The infants' dermatitis quality of life index","volume":"144","author":"Lewis-Jones","year":"2001","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.09.059_bib31","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","article-title":"The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.09.059_bib32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/bjd.12590","article-title":"Translating Patient-Oriented Eczema measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods","volume":"169","author":"Charman","year":"2013","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.09.059_bib33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2133.1998.02034.x","article-title":"The family impact of childhood atopic dermatitis: the Dermatitis Family Impact Questionnaire","volume":"138","author":"Lawson","year":"1998","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.09.059_bib34","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/bjd\/ljae287","article-title":"A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register","volume":"191","author":"Alexander","year":"2024","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.09.059_bib35","first-page":"AB168","article-title":"Dupilumab monotherapy improves atopic dermatitis lesions and post-inflammatory hyperpigmentation in patients with skin of color and moderate-to-severe atopic dermatitis","volume":"95","author":"Alexis","year":"2026","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.09.059_bib36","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.jaci.2021.02.034","article-title":"Health disparities in allergic and immunologic conditions in racial and ethnic underserved populations: a Work Group Report of the AAAAI Committee on the underserved","volume":"147","author":"Davis","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2026.09.059_bib37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/DER.0000000000000323","article-title":"Predictors of hospitalization, length of stay, and costs of care among adult and pediatric inpatients with atopic dermatitis in the United States","volume":"29","author":"Narla","year":"2018","journal-title":"Dermatitis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226036029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:28:10Z","timestamp":1793370490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226036029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"alternative-id":["S0190962226036029"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.059","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world systemic treatment outcomes for moderate-to-severe atopic dermatitis in children by skin color: 4-year results from the observational, international, real-world PEDISTAD registry","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.09.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}